Earnings To Watch UGI Corp Reports Q4 2024 Result
| BIVRX Fund | USD 17.16 0.25 1.48% |
Slightly above 52% of Balter Invenomic's investors are presently thinking to get in. The analysis of overall sentiment of trading Balter Invenomic Fund mutual fund suggests that some investors are interested at this time. Balter Invenomic's investing sentiment can be driven by a variety of factors including economic data, Balter Invenomic's earnings reports, geopolitical events, and overall market trends.
Balter |
UGI Corp is set to release its Q4 2024 earnings on Nov 21, 2024. The consensus estimate for Q4 2024 revenue is 1.65 billion, and the earnings are expecte
Read at gurufocus.com
 |
Balter Invenomic Fundamental Analysis
We analyze Balter Invenomic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Balter Invenomic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Balter Invenomic based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Balter Invenomic is currently under evaluation in total asset among similar funds. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Balter Invenomic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Balter Invenomic mutual fund to make a market-neutral strategy. Peer analysis of Balter Invenomic could also be used in its relative valuation, which is a method of valuing Balter Invenomic by comparing valuation metrics with similar companies.
Peers
Balter Invenomic Related Equities
| NEITX | Nebraska Municipal | 0.32 | ||||
| OKMUX | Oklahoma Municipal | 0.28 | ||||
| BXDYX | Barings Active | 0.22 | ||||
| PATFX | T Rowe | 0.18 | ||||
| MGGNX | Mirova Global | 0.11 | ||||
| MDMTX | Blrc Sgy | 0.09 | ||||
| TTRBX | Ambrus Core | 0.10 | ||||
| BSGAX | Sterling Capital | 0.12 |
Other Information on Investing in Balter Mutual Fund
Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |